Skip to main content

A Peptide Inhibitor of Glucagon-Responsive Adenylate Cyclase in Liver

  • Conference paper
GLUCAGON: Its Role in Physiology and Clinical Medicine
  • 103 Accesses

Abstract

The effects of a peptide inhibitor of adenylate cyclase produced by the isolated, perfused rat liver under hypocalcemic conditions were studied. This inhibitory peptide non-competitively abolished the activation of adenylate cyclase in particulate preparations of rat liver by glucagon, epinephrine, and parathyroid hormone, as well as cyclic AMP production in glucagon-stimulated rat liver slices. Higher concentrations of inhibitor also decreased basal adenylate cyclase activity and its fluoride-responsiveness. The data suggest that this substance is normally present in liver, but is released only under hypocalcemic conditions. The peptide does not crossreact in the radioimmunoassay of glucagon, insulin, or parathyroid hormone. Its inhibitory effects are not duplicated by somatostatin, angiotensin I, renin substrate, or the desoctadecapeptide of insulin.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Gilman, A. G. (1970): A protein binding assay for adenosine S-cyclic monophosphate. Proc. Nat. Acad. Sci. USA 67, 305–312.

    Google Scholar 

  2. Ho, R. J. and Sutherland, E. W. (1971): Formation and release of a hormone antagonist by rat adipocytes. J. Biol. Chem. 246, 6822–6827.

    Google Scholar 

  3. Ho, R. J. and Sutherland, E. W. (1974): Inhibition of adenylate cyclase by a factor isolated from human plasma. Fed. Proc. 33, 480 (abst.)

    Google Scholar 

  4. Krishna, G., Weiss, B. and Brodie, B. B. (1968): A simple sensitive method for the assay of adenyl cyclase. J. Pharmacol. Exp. Ther. 163, 379–385.

    Google Scholar 

  5. Levey, G. S., Lehotay, D. C., Canterbury, J. M., Bricker, L. A. and Meltz, G. J. (1975): Isolation of a unique peptide inhibitor of hormone-responsive adenylate cyclase. J. Biol. Chem. 250, 5730–5733.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1977 Springer-Verlag New York Inc.

About this paper

Cite this paper

Lehotay, D.C., Levey, G.S., Canterbury, J.M., Bricker, L.A., Ruiz, E. (1977). A Peptide Inhibitor of Glucagon-Responsive Adenylate Cyclase in Liver. In: Foà, P.P., Bajaj, J.S., Foà, N.L. (eds) GLUCAGON: Its Role in Physiology and Clinical Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-6366-1_25

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-6366-1_25

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-6368-5

  • Online ISBN: 978-1-4612-6366-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics